IRIS
CONTE, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.299
Totale 1.299
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.299
Totale 1.299
Salva come PNG Salva come JPEG
Città #
Genova 865
Rapallo 245
Genoa 176
Bordighera 13
Totale 1.299
Salva come PNG Salva come JPEG
Nome #
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 128
Management of young women with early breast cancer 113
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 104
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy 99
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 88
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 86
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 80
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancer 76
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial 75
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 66
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 58
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers 54
Update on the management of breast cancer during pregnancy 50
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer 49
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 47
De novo Metastatic Breast Cancer Arising in Young Women: Review of the Current Evidence 43
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients 41
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate 38
Endocrine‐based treatments in clinically‐relevant subgroups of hormone receptor‐positive/her2‐negative metastatic breast cancer: Systematic review and meta‐analysis 28
null 27
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 19
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials 4
Totale 1.373
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.627
article - articoli 5.627
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 0 0 0 0 0 0 0 0 20 18
2019/2020406 9 11 3 20 36 61 67 52 46 57 29 15
2020/2021211 13 21 18 16 19 21 15 20 14 27 12 15
2021/2022254 19 6 12 28 13 19 15 46 33 21 9 33
2022/2023301 30 42 2 29 49 40 4 13 49 2 39 2
2023/2024136 4 18 5 28 11 23 20 9 5 13 0 0
Totale 1.373